Cell biology of parathyroid gland hyperplasia in chronic renal failure

Journal of the American Society of Nephrology

Volumn 11, Issue 6, 2000, Pages 1141-1152

  Drüeke, Tilman B ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Necker Institute   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; KI 67 ANTIGEN; MEMBRANE RECEPTOR; MESSENGER RNA; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; VITAMIN D RECEPTOR;

APOPTOSIS; CELL GROWTH; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CYTOLOGY; ECHOGRAPHY; GENE; HUMAN; NONHUMAN; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 0343238871     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1161141     Document Type: Review

References (102)

1. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993
2. Bikle DD: Clinical counterpoint. Vitamin D: New actions, new analogs, new therapeutic potential. Endocr Rev 13: 765-784, 1992
3. Almadén Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M: Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11: 970-976, 1996
4. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97: 2534-2540, 1996
5. Yalcindag C, Silver J, Naveh-Many T: Mechanism of increased parathyroid hormone mRNA in experimental uremia: Roles of protein RNA binding and RNA degradation. J Am Soc Nephrol 10: 2562-2568, 1999
6. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y: Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92: 1436-1442, 1993
7. Patel S, Ke HQ, Vanholder R, Hsu CH: Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. Kidney Int 46: 129-133, 1994
8. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH: Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96: 50-59, 1995
9. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81: 1598-1606, 1996
10. Gogusev J, Duchambon P, Hory B, Giovannini M, Sarfati E, Drüeke TB: Depressed expression of calcium receptor in parathyroid gland tissue of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 51: 328-336, 1997
11. Baserga R: The Biology of Cell Reproduction, Cambridge, MA, Harvard University Press, 1985
12. Wang Q, Palnitkar S, Parfitt AM: Parathyroid cell proliferation in the rat: Effect of age and of phosphate administration and recovery. Endocrinology 137: 4558-4562, 1996
13. Wang Q, Palnitkar S, Parfitt AM: The basal rate of cell proliferation in normal human parathyroid tissue: Implications for the pathogenesis of hyperparathyroidism. Clin Endocrinol 46: 343-349, 1997
14. Abbona GC, Papotti M, Gasparri G, Bussolati G: Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26: 135-138, 1995
15. Yamaguchi S, Yachiku S, Morikawa M: Analysis of proliferate activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Clin Endocrinol Metab 82: 2681-2688, 1997
16. Naveh-Many T, Rahamimov R, Livni N., Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 1786-1793, 1995
17. Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H, Nagano N: The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100: 2977-2983, 1997
18. Sugenoya Y, Yoshimura A, Uda S, Inui K, Iwasaki S, Taira T, Ideura T: Expression of apoptosis-preventing Bcl-2 and its counteractive Bax is associated with cell proliferation in secondary hyperparathyroidism (II-HPT) [Abstract]. J Am Soc Nephrol 7: 1499A, 1996
19. Wang W, Johannson H, Kvasnicka T, Farnebo L-O, Grimelius L: Detection of apoptotic cells and expression of Ki-67 antigen, bcl-2, p53 oncoproteins in human parathyroid adenoma. Acta Pathol Microbiol Immunol Scand 104: 789-796, 1996
20. Zhang P, Gogusev J, Duchambon P, Sarfati E, Drüeke T: Apoptosis in patients with primary (I°) or secondary (II°) hyperparathyroidism (HPTH) [Abstract]. J Am Soc Nephrol 7: 1504, 1996
21. Drüeke TB, Zhang P, Gogusev J: Apoptosis: Background and possible role in secondary hyperparathyroidism [Invited Comment]. Nephrol Dial Transplant 12: 2228-2233, 1997
22. Zhang P, Duchambon P, Gogusev J, Nabarra B, Bourdeau A, Drüeke TB: Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 57: 437-445, 2000
23. Drüeke T: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48: 259-272, 1995
24. Parfitt AM: The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 52: 3-9, 1997
25. Silver J, Sela SB, Naveh-Many T: Regulation of parathyroid cell proliferation. Curr Opin Nephrol Hypertens 6: 321-326, 1997
26. Takahashi F, Finch J, Brown AJ, Slatopolsky E: The effects of low phosphorus diet on the secretion of PTH in establishing diffuse parathyroid hyperplasia [Abstract]. J Am Soc Nephrol 8: 508A, 1997
27. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E: Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 6: 162-169, 1991
28. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K: Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus. Nephron 70: 242-248, 1995
29. 2 Vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35: 1045-1056, 1989
30. Wernerson A, Svensson O, Reinholt FP: Quantitative and three-dimensional aspects of the rat parathyroid gland in normo-, hypo- and hypercalcemia. Microsc Res Tech 32: 129-147, 1995
31. Platt H: Mitotic activity in the parathyroid glands of the rat following bilateral nephrectomy. J Pathol Bacteriol 62: 383-387, 1950
32. Denda M, Finch J, Slatopolsky E: Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28: 596-602, 1996
33. Fukagawa M, Kaname S-Y, Igarashi T, Ogata E, Kurokawa K: Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 39: 874-881, 1991
34. Sakaguchi K: Acidic fibroblast growth factor autocrine system as a mediator of calcium-regulated parathyroid cell growth. J Biol Chem 267: 24554-24562, 1992
35. Matsushita H, Hara M, Endo Y, Shishiba Y, Hara S, Ubara Y, Nakazawa H, Suzuki N, Kawaminami K, Kido T, Li Q, Grimelius L: Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia. Kidney Int 55: 130-138, 1999
36. Wysolmerski JJ, Stewart AF: The physiology of parathyroid hormone-related protein: An emerging role as a developmental factor. Annu Rev Physiol 60: 431-460, 1998
37. Gogusev J, Duchambon P, Stoermann-Chopard C, Giovannini M, Sarfati E, Drüeke TB: De novo expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 11: 2155-2162, 1996
38. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA: Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 55: 1284-1292, 1999
39. Carling T, Rastad J, Åkerström G, Westin G: Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 83: 2255-2259, 1998
40. Carling T, Kindmark A, Hellman P, Holmberg L, Åkerström G, Rastad J: Vitamin D receptor alleles b, a, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN1. Biochem Biophys Res Commun 231: 329-332, 1997
41. Olmos JM, Martinez J, de Francisco AL, Riancho JA, Amado JA, Gonzalez-Macias J: 1,25-Dihydroxyvitamin D3 receptors in peripheral blood mononuclear cells from patients with renal insufficiency. Methods Find Exp Clin Pharmacol 20: 699-707, 1998
42. Slatopolsky E, Delmez E: Pathogenesis of secondary hyperparathyroidism. Miner Electrolyte Metab 21: 91-96, 1995
43. McGregor RR, Sarras MP, Houle H, Cohn DV: Primary monolayer culture of bovine parathyroids: Effect of calcium, isoproterenol, and growth factors. Mol Cell Endocrinol 30: 313-328, 1983
44. LeBoff MS, Rennke HG, Brown EM: Abnormal regulation of parathyroid cell secretion and proliferation in primary cultures of bovine parathyroid cells. Endocrinology 113: 277-284, 1983
45. LeBoff MS, Shoback D, Brown EM, Thatcher J, Leombruno R, Beaudoin D, Henry M, Wilson R, Pallotta J, Marynick S, Stock J, Leight G: Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest 75: 49-57, 1985
46. Ridgeway RD, Hamilton JW, Gregor RRM: Characteristics of bovine parathyroid cell organoid in culture. In Vitro Cell Dev 22: 91-99, 1998
47. Brandi ML, Fitzpatrick LA, Coon HG, Aurbach GD: Bovine parathyroid cell: Cultures maintained for more than 140 population doublings. Proc Natl Acad Sci USA 83: 1709-1713, 1986
48. 2+ -sensing receptor messenger ribonucleic acid and protein. Endocrinology 136: 3087-3092, 1995
49. Brown AJ, Zhong M, Ritter CS, Brown EM, Slatopolsky E: Loss of calcium responsiveness in cultured parathyroid cells is associated with decreased calcium receptor expression. Biochem Biophys Res Commun 212: 861-867, 1995
50. Brandi ML, Ornberg RL, Sakaguchi K, Curcio F, Fattorossi A, Lelkes PI, Matsui T, Zimering M, Aurbach GD: Establishment and characterization of a clonal line of parathyroid endothelial cells. FASEB J 4: 3152-3158, 1990
51. Nielsen PK, Feldt-Rasmussen U, Olgaard K: A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11: 1762-1768, 1996
52. Sugimoto T, Kanatani M, Kano J, Kobayashi T, Yamaguchi T, Fukse M, Chihara K: IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation. Am J Physiol 266: E709-E716, 1994
53. Kallay E, Kifor O, Chattopadhyay N, Brown EM, Bischof MG, Peterlik M, Cross HS: Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: A role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun 232: 80-83, 1997
54. Mailland M, Waelchli R, Ruat M, Boddeke HG, Seuwen K: Stimulation of cell proliferation by calcium and a calcimimetic compound. Endocrinology 138: 3601-3605, 1997
55. Kremer R, Bolivar I, Goltzman D, Hendy GN: Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125: 935-941, 1989
56. 3 of cell proliferation and function of bovine parathyroid cells in culture. J Bone Miner Res 5: 755-760, 1990
57. 2+-sensing receptor expression in functionally active, long-term human parathyroid cell cultures. J Bone Miner Res 13: 1-9, 1998
58. 3H)-thymidine uptake by calcium and calcitriol in human PT tissue [Abstract]. J Am Soc Nephrol 6: 958A, 1995
59. Itin PH, Pittelkow MR, Kumar R: Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 135: 1793-1798, 1994
60. Pillai S, Bikle D, Su MJ, Ratnam A, Abe J: 1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels. J Clin Invest 96: 602-609, 1995
61. 2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97: 1577-1588, 1996
62. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153, 1996
63. 2 D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int 43: 213-218, 1988
64. Green J, Kleeman CR, Schotland S, Chaimovitz C: Acute phosphate depletion dissociates hormonal stimulated second messengers in osteoblast-like cells. Endocrinology 129: 848-858, 1991
65. Mendes V, Jorgetti V, Nemeth J, Dubost C, Lavergne A, Cournot G, Lecharpentier Y, Drüeke T: Secondary hyperparathyroidism in chronic haemodialysis patients: A clinico-pathologic study. Proc Eur Dial Transplant Assoc 20: 731-738, 1983
66. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H: Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13: 78-86, 1997
67. De Francisco AM, Ellis HA, Owen JP, Cassidy MJD, Farndon JR, Ward MK, Kerr DNS: Parathyroidectomy in chronic renal failure. Q J Med 55: 289-315, 1985
68. Loda M, Lipman J, Cukor B, Bur M, Kwan P, Delellis RA: Nodular foci in parathyroid adenomas and hyperplasias: An immunohistochemical analysis of proliferative activity. Hum Pathol 25: 1050-1056, 1994
69. Tominaga Y, Grimelius L, Falkmer U, Johansson H, Falkmer S: DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse. Anal Cell Pathol 3: 325-333, 1991
70. Wallfelt CH, Larsson R, Gylfe E, Ljunghall S, Rastad J, Åkerström G: Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: Implications for parathyroid autotransplantation. World J Surg 12: 431-438, 1988
71. Oka T, Yoshioka T, Shrestha GR, Koide T, Sonoda T, Hosokawa S, Onoe K, Sakurai M: Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism. Virchows Arch 413: 53-60, 1988
72. Hörandner H, Neyer U, Gruber U, Zimmermann G, Haid A, Niederle B: Pathomorphologie von autotransplantiertem Nebenschilddrüsengewebe. Nieren Hochdruckkr 26: 319-327, 1997
73. Juhlin C, Rastad J, Klareskog L, Grimelius L, Åkerström G: Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am J Pathol 135: 321-328, 1989
74. Fujisaki T, Hida M, Hiraga S, Osamura RY: Cellular proliferation and secretion in secondary hyperparathyroidism during renal failure. Nephron 77: 68-75, 1997
75. Niederle B, Hörandner H, Roka R, Woloszek W, Waldhor TH: Parathyreoidektomie und Autotransplantation beim renalen Hyperparathyreoidismus. Langenbecks Arch 373: 337-355, 1988
76. Ohta K, Manabe T, Katagiri M, Harada T: Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism. World J Surg 18: 625-632, 1994
77. Abbona G, Papotti M, Gasparri G, Bussolati G: Recurrence in parathyroid hyperplasias owing to secondary hyperparathyroidism is predicted by morphological patterns and proliferative activity values. Endocr Pathol 7: 55-61, 1996
78. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H: Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 16: 595-603, 1992
79. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB: Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95: 2047-2054, 1995
80. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Tagaki H: Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20: 744-752, 1996
81. Chudek J, Ritz E, Kovacs G: Genetic abnormalities in parathyroid nodules of uremic patients. Clin Cancer Res 4: 211-214, 1998
82. Lubensky IA, Delebenko LV, Zhuang ZP, Emmertbuck MR, Dong QH, Chandrasekharappa S, Guru SC, Manickam P, Olufemi SE, Marx SJ, Spiegel AM, Collins FS, Liotta LA: Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56: 5272-5278, 1996
83. Malachi T, Zevin D, Gafter U, Chagnac A, Slor H, Levi L: DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 44: 385-389, 1993
84. Farnebo F, Teh BT, Dotzenrath C, Wassif WS, Svennson A, White I, Betz R, Goretzki P, Sandelin K, Farnebo L-O, Larsson C: Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet 99: 342-349, 1997
85. Palanisamy N, Tahara H, Imanishi Y, Salusky I, Goodman W, Brandi ML, Drüeke TB, Sarfati E, Ureña P, Chaganti RSK, Arnold A: Novel clonal chromosomal defects identified by comparative genomic hybridization and molecular allotyping in refractory hyperparathyroidism of uremia [Abstract]. J Bone Miner Res 23[Suppl]: S188, 1998
86. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML: Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76: 139-144, 1993
87. Inagaki C, Dousseau M, Pacher N, Sarfati E, Drüeke TB, Gogusev J: Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 13: 350-357, 1998
88. Degenhardt S, Toell A, Weideman W, Dotzenrath C, Spindler K-D, Grabensee B: Point mutations of the human parathyroid calcium receptor gene are not responsible for non-suppressible renal hyperparathyroidism. Kidney Int 53: 556-561, 1998
89. Miki H, Sumitomo M, Inoue H, Kita S, Monden Y: Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis [Review]. Surgery 120: 897-901, 1996
90. Djema AI, Mahmoud MD, Collin P, Heyman MF: Hyperparathyroïdie tertiaire: Cancer parathyroïdien avec métastases hépatiques chez un hémodialysé. Néphrologie 19: 121-123, 1998
91. Takami H, Kameyama K, Nagakubo I: Parathyroid carcinoma in a patient receiving long-term hemodialysis. Surgery 125: 239-240, 1999
92. Canalejo A, Almaden Y, Felsenfeld A, Rodriguez M: The effect of calcitriol on parathyroid cell cycle and apoptosis in vitro [Abstract]. J Am Soc Nephrol 7: 1811, 1996
93. Heidenreich S, Schmidt M, Bachmann J, Harrach B: Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 49: 792-799, 1996
94. Fadda SG, Massry SG: Chronic renal failure is a state of cellular calcium toxicity [Review]. Am J Kidney Dis 21: 81-86, 1993
95. Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Aljama P: Nonbiocompatible hemodialysis membranes induce apoptosis in mononuclear cells: The role of G-proteins. J Am Soc Nephrol 9: 46-53, 1998
96. Lewin E, Wang W, Olgaard K: Reversibility of experimental secondary hyperparathyroidism. Kidney Int 52: 1232-1241, 1997
97. Henry HL, Taylor AN, Norman AW: Response of chick parathyroid glands to the vitamin D metabolite 1,25-cholecalciferol. J Nutr 107: 1918-1926, 1977
98. Cloutier M, Brossard JH, Gascon-Barre M, D'Amour P: Lack of involution of hyperplastic parathyroid glands in dogs: Adaptation via a decrease in the calcium stimulation set point and a change in secretion profile. J Bone Miner Res 9: 621-629, 1994
99. Nylen E, Shah A, Hall J: Spontaneous remission of primary hyperparathyroidism from parathyroid apoplexy. J Clin Endocrinol Metab 81: 1326-1328, 1996
100. Fukagawa M, Okazaki R, Takano K, Kaname S-Y, Ogata E, Harada S-I, Sekine N, Matsumoto T, Kurokawa K: Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 323: 421-422, 1990
101. Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda S, Bartholomay D, Lobaugh BA: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45: 1710-1721, 1994
102. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E: Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68: 221-228, 1994